Advertisement
Screener

BIOCRYST PHARMACEUTICALS, INC. (BCRX) Pre-Tax Margin

BIOCRYST PHARMACEUTICALS, INC. (BCRX) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 36.41%.
  • 2026-03-31: Pre-Tax Margin -460.84%.
  • 2025-12-31: Pre-Tax Margin 61.00%.
  • 2025-09-30: Pre-Tax Margin 7.61%.

Complete source-backed pre-tax margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-3036.41%
2026-03-31-460.84%
2025-12-3161.00%
2025-09-307.61%
2025-06-303.97%
2025-03-310.52%
2024-12-31-19.76%
2024-09-30-11.48%
2024-06-30-11.43%
2024-03-31-37.75%
2023-12-31-67.62%
2023-09-30-41.29%
2023-06-30-90.42%
2023-03-31-76.57%
2022-12-31-89.84%
2022-09-30-54.07%
2022-06-30-88.51%
2022-03-31-148.06%
2021-12-31-32.92%
2021-09-30-143.44%
2021-06-30-86.47%
2021-03-31-337.29%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-3130.56%
2024-12-31-19.29%
2023-12-31-68.26%
2022-12-31-90.24%
2021-12-31-115.68%
2020-12-31-1026.35%
2019-12-31-222.99%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43